Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1994 Jun;191(3):639-46.
doi: 10.1148/radiology.191.3.8184040.

Contrast-enhanced MR imaging of the breast: comparison of two different doses of gadopentetate dimeglumine

Affiliations
Comparative Study

Contrast-enhanced MR imaging of the breast: comparison of two different doses of gadopentetate dimeglumine

S H Heywang-Köbrunner et al. Radiology. 1994 Jun.

Abstract

Purpose: To optimize detection and diagnosis of breast lesions with contrast-enhanced magnetic resonance (MR) imaging.

Materials and methods: A three-dimensional fast low-angle shot pulse sequence was used for a group comparison consisting of 76 high-dose (0.16 mmol gadopentetate dimeglumine per kilogram of body weight) and 76 low-dose (0.1 mmol/kg) examinations. Intraindividual comparisons were possible in a subgroup of 20 patients.

Results: Enhancement with the high dose was about 1.5 times higher for benign and malignant tissues. With the lower dose, no false-positive findings could be avoided and definition of a threshold that excluded false-negative findings was problematic. Conspicuity of malignant lesions was much improved with the higher dose (a good to excellent rating in 81% vs 26% with the lower dose). Three small foci were visible only with the higher dose.

Conclusion: The higher dose of contrast material allowed much better results. Dose comparison studies are also recommended for other techniques.

PubMed Disclaimer

Publication types

MeSH terms

LinkOut - more resources